Practice Area Focus Patent Prosecution Patent Transactions and Strategic Counseling Due Diligence Patent Analysis and Opinions Portfolio Management Patent Interferences, Reissue and Reexamination Proceedings Intellectual Property Licensing Trade Secrets Trademark Prosecution
Licensed to Practice In District of Columbia Virginia Illinois U.S. Court of Appeals, Federal Circuit U.S. Patent and Trademark Office
Education The John Marshall Law School, J.D. 1995 The University of Minnesota, B.S./B.A. Microbiology 1991 ______________________________________________________________________
Todd Juneau is the firm founder and managing partner. Mr. Juneau has over 14 years experience as Registered Patent Attorney, focusing his practice on patent prosecution, in the building of domestic and international patent & trademark portfolios, analyzing patent positions and patent validity, particularly in the pharmaceutical, telecommunication, medical device, and biotechnology sectors, and providing advice to corporations and universities regarding patent & trademark matters.
Over his career, Mr. Juneau has written, filed, and managed over 300 U.S. patent applications and over 1200 international applications. In the last 2 years, Mr. Juneau has written, filed, and managed 30 U.S. patent applications for a major university in various technologies, in addition to filing, prosecuting and managing three dozen National Phase applications for a European client in the area of biotechnology. Mr. Juneau's practice has encompassed large corporations, start-up companies, major universities, and medical schools from around the world.
Before starting his own firm, Mr. Juneau was a partner at mid-size Washington, D.C. patent & trademark law firm where he worked for 9 years. During that time Mr. Juneau represented large pharmaceutical companies from France, Germany, Israel, Japan, Switzerland, the United Kingdom, and the United States; multinational conglomerate companies; chemical companies; polymer companies, biomedical companies; biotechnology companies; telecommunications (hardware and software) companies. Mr. Juneau managed part of a chemical and biotech department, overseeing a global portfolio covering a $2 billion a year proton pump inhibitor drug, a U.S. Portfolio for recombinant proteins and cancer therapies for start-up company, as well as a Global Portfolio with more than 1,000 patent filings for a small molecule neuro drug, to a name a few experiences.
JUNEAU PARTNERS 333 N. Fairfax Street, Suite 305 Alexandria, Virginia 22314 Tel (703) 548-3569 Fax (703) 940-1142
